Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Water Technologies is a biotechnology company specializing in the production and therapeutic application of deuterium-depleted water (DDW). Based in Romania, the company utilizes advanced isotopic separation technologies to produce its flagship product, Qlarivia, which features a significantly lower deuterium concentration than standard water. NWT's research focuses on the biological impact of deuterium depletion on cellular processes, including mitochondrial efficiency, DNA stability, and tumor cell proliferation. The company's products are marketed as adjuvant therapies for oncology patients and for the management of metabolic and dermatological conditions. NWT collaborates with various research institutes to validate the clinical benefits of DDW in chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Water Technologies.